Clinical Investigation for Virus-Host Interactions and its Implication in the Development of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).

病毒-宿​​主相互作用的临床研究及其对 HTLV-1 相关脊髓病/热带痉挛性截瘫 (HAM/TSP) 发展的影响。

基本信息

项目摘要

Human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is observed only in 1-2% of HTLV-1 infected individuals. We have previously reported that HTLV-1 Tax subtype, several HLA and non-HLA genes are closely associated with the development of HAM/TSP. Based on these findings, we developed the best-fit logistic regression equation to predict the odds of HAM/TSP. We applied this equation to 181 consecutively ascertained healthy HTLV-1 carriers (HCs) and found a significant association between a high odds of HAM/TSP and two factors: brisk patellar deep tendon reflexes, which suggest latent central nervous system compromise, and flower cell (ATL cell)-like abnormal lymphocytes. Our data suggests the usefulness of our equation for detecting subclinical HAM/TSP-related neurological abnormalities. We further analyzed CD4+ and CD8+ T cells in PBMCs from HAM/TSP patients, HCs and normal uninfected controls by flow cytometry based analyses. We have used synthetic tetramers composed of HLA and its immunodominant epitope peptide to analyze Env-specific CD4+ T and Tax-specific CD8+ T cells directly from peripheral blood. Significantly higher frequency of activated and clonally expanded tetramer+CD4+ and tetramer+CD8+ T cells were observed in HAM/TSP patients than HCs, suggesting that active and continus expansion of HTLV-1 specific T cells during chronic infection play a role in the development of HAM/TSP.
人类t细胞嗜淋巴病毒1型(HTLV-1)相关脊髓病/热带痉挛性麻痹(HAM/TSP)仅在HTLV-1感染个体的1-2%中观察到。我们之前报道HTLV-1 Tax亚型、几种HLA和非HLA基因与HAM/TSP的发生密切相关。基于这些发现,我们开发了最佳拟合逻辑回归方程来预测HAM/TSP的几率。我们将该方程应用于181名连续确定的健康HTLV-1携带者(hc),发现HAM/TSP的高几率与两个因素之间存在显著关联:活跃的髌骨深腱反射,这表明中枢神经系统存在潜在的损害,以及花细胞(ATL细胞)样异常淋巴细胞。我们的数据表明我们的方程对于检测亚临床HAM/ tsp相关的神经异常是有用的。我们进一步通过流式细胞术分析了HAM/TSP患者、hc和正常未感染对照的pbmc中的CD4+和CD8+ T细胞。我们使用由HLA及其免疫优势表位肽组成的合成四聚体直接从外周血中分析env特异性CD4+ T和tax特异性CD8+ T细胞。HAM/TSP患者中激活和克隆扩增的四聚体+CD4+和四聚体+CD8+ T细胞的频率明显高于hcc,提示慢性感染期间HTLV-1特异性T细胞的活跃和持续扩增在HAM/TSP的发展中起作用。

项目成果

期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
HTLV-Iと疾患(分担) HAM/TSPの免疫遺伝学
HTLV-I与疾病(分享)HAM/TSP的免疫遗传学
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tsumoto K;Ejima A;Senczuk M;Kita Y;Arakawa T.;齊藤峰輝
  • 通讯作者:
    齊藤峰輝
Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological disease.
细胞外基质蛋白的遗传变异是发生 HTLV-I 相关神经系统疾病风险的决定因素。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nobuhara Y;et al.
  • 通讯作者:
    et al.
Abnormalities of spinal MRIs implicate clinical variability in HTLV-I-associated myelopathy.
脊髓 MRI 的异常表明 HTLV-I 相关脊髓病的临床变异。
Geographical distribution and disease associations of the CD45 exon 6 138G variant.
CD45 外显子 6 138G 变体的地理分布和疾病关联。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Fujio Umehara;Kenichi Mishima;Nobuaki Egashira;Ayumi Ogata;Katsunori Iwasaki;Michihiro Fujiwara.;Ward V
  • 通讯作者:
    Ward V
Flow cytometry evaluation of the T-cell receptor Vβ repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals : Effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
流式细胞术评估人 T 细胞嗜淋巴细胞病毒 1 型 (HTLV-1) 感染个体中 T 细胞受体 Vβ 库:干扰素 α 治疗对 HTLV-1 相关脊髓病/热带痉挛性截瘫 (HAM/TSP) 的影响
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAITO Mineki其他文献

SAITO Mineki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAITO Mineki', 18)}}的其他基金

Analysis of chronic inflammation caused by HTLV-1 infection and development of novel strategies to prevent HTLV-1 associated diseases.
分析 HTLV-1 感染引起的慢性炎症并制定预防 HTLV-1 相关疾病的新策略。
  • 批准号:
    24590556
  • 财政年份:
    2012
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The use of novel humanized mouse model for the study of immunotherapy against HTLV-1 infection
使用新型人源化小鼠模型研究HTLV-1感染的免疫治疗
  • 批准号:
    21590512
  • 财政年份:
    2009
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant for R&D
Molecular Tool Development to Identify, Isolate, and Interrogate the Rod Microglia Phenotype in Neurological Disease and Injury
开发分子工具来识别、分离和询问神经系统疾病和损伤中的杆状小胶质细胞表型
  • 批准号:
    10599762
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Correction of Neurological Disease via Allele Specific Excision of Pathogenic Repeats
通过等位基因特异性切除致病重复序列来纠正神经系统疾病
  • 批准号:
    10668665
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Mechanistic Basis for Non-Canonical Translation in Neurological Disease
神经系统疾病非规范翻译的机制基础
  • 批准号:
    10591832
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Organotypic whole hemisphere models to probe structure-function in neurodevelopment and neurological disease
用于探索神经发育和神经系统疾病结构功能的器官型全半球模型
  • 批准号:
    2222074
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Standard Grant
Investigating RNA dysregulation in Neurological Disease through study of Pontocerebellar Hypoplasia Type 1b
通过 1b 型桥小脑发育不全研究来调查神经系统疾病中的 RNA 失调
  • 批准号:
    10638196
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Brain Cholesterol Biosynthesis in Health and Neurological Disease
健康和神经系统疾病中的脑胆固醇生物合成
  • 批准号:
    10574830
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
Enhancing the Engraftment of Microglia for the Treatment of Neurological Disease
增强小胶质细胞的植入以治疗神经系统疾病
  • 批准号:
    10382086
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
Repeat expansions in neurological disease: discovery, interpretation and enhanced diagnostics
神经系统疾病的重复扩展:发现、解释和增强诊断
  • 批准号:
    nhmrc : 2001513
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Ideas Grants
Pathophysiological roles of convulsive neurological disease-causing gene PRRT2 in neurotransmitter release
惊厥神经疾病致病基因 PRRT2 在神经递质释放中的病理生理作用
  • 批准号:
    21H02809
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了